Axcellant is excited to announce our participation at the European Association of Nuclear Medicine (EANM) Congress in Hamburg from October 19-23, 2024. We invite you to visit us and explore how our innovative CRO services in clinical trials and nuclear medicine can support your research and development efforts.
Our team will be available throughout the event to discuss cutting-edge solutions in medical imaging and radiopharmaceutical development. Whether you’re interested in exploring partnership opportunities or learning about our latest projects, we look forward to connecting with you.
See you in Hamburg!
Marking a significant achievement in our ongoing efforts to advance medical device research, we have successfully concluded a PMCF study…
Initiating a clinical trial is akin to embarking on a voyage of discovery in the realm of medicine. This journey,…
Our team at Axcellant is proud to announce the completion of a significant Post-Market Clinical Follow-up study. This study was…
Copyright @ 2025 Axcellant. Designed By Frantic